Back

Aberrant expression of the testis kinase TSSK6 activates FAK-STAT3 signaling to promote tumorigenic growth

Delgado, M.; Costello, I.; Potturi, S.; Gibbs, Z.; Whitehurst, A. W.

2026-03-13 cancer biology
10.64898/2026.03.10.710807 bioRxiv
Show abstract

Cancer-testis antigens (CTAs) are germ cell-restricted proteins aberrantly expressed in diverse malignancies, yet whether these proteins contribute to tumor progression remains poorly defined. The CTA Testis-Specific Serine Kinase 6 (TSSK6) is frequently expressed in colorectal cancer (CRC), where it promotes key hallmarks of tumor progression, including anchorage-independent growth, invasion, and in vivo tumor formation. However, the signaling network by which ectopic TSSK6 drives these phenotypes has not been established. Here, we define the signaling pathways regulated by TSSK6 in CRC cells. We demonstrate that TSSK6 promotes focal adhesion kinase (FAK) activation, leading to enhanced STAT3 Ser727 phosphorylation and increased STAT3-dependent transcription. Transcriptomic analyses revealed induction of gene programs enriched for extracellular matrix remodeling, cytoskeletal organization, adhesion, and motility in a STAT3-dependent manner. Disruption of the FAK-STAT3 signaling axis abrogated anchorage-independent growth and invasive outgrowth in a spheroid model. Collectively, these findings demonstrate that aberrant expression of a germline-restricted kinase promotes focal adhesion signaling, which activates STAT3-dependent transcriptional programs that promote anoikis resistance and invasive behavior in CRC.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Oncogene
76 papers in training set
Top 0.1%
25.7%
2
Cell Reports
1338 papers in training set
Top 4%
8.4%
3
Cancer Research
116 papers in training set
Top 0.3%
6.3%
4
Journal of Clinical Investigation
164 papers in training set
Top 0.6%
4.3%
5
JCI Insight
241 papers in training set
Top 0.9%
4.3%
6
eLife
5422 papers in training set
Top 22%
3.9%
50% of probability mass above
7
Gastroenterology
40 papers in training set
Top 0.6%
3.6%
8
Cancer Discovery
61 papers in training set
Top 1.0%
1.9%
9
Molecular Cancer Research
42 papers in training set
Top 0.3%
1.8%
10
Nature Communications
4913 papers in training set
Top 50%
1.8%
11
Cancers
200 papers in training set
Top 3%
1.7%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.5%
13
Developmental Cell
168 papers in training set
Top 9%
1.3%
14
Communications Biology
886 papers in training set
Top 13%
1.3%
15
Genome Medicine
154 papers in training set
Top 5%
1.3%
16
Cell Reports Medicine
140 papers in training set
Top 5%
1.2%
17
Scientific Reports
3102 papers in training set
Top 67%
1.2%
18
iScience
1063 papers in training set
Top 22%
1.2%
19
Journal of Biological Chemistry
641 papers in training set
Top 3%
1.2%
20
Journal of Experimental Medicine
106 papers in training set
Top 3%
0.9%
21
Molecular Cancer
14 papers in training set
Top 0.7%
0.9%
22
Cell Death & Disease
126 papers in training set
Top 2%
0.8%
23
Journal of Cell Biology
333 papers in training set
Top 4%
0.8%
24
Clinical Cancer Research
58 papers in training set
Top 2%
0.7%
25
PLOS ONE
4510 papers in training set
Top 68%
0.7%
26
npj Precision Oncology
48 papers in training set
Top 1%
0.7%
27
Cell Communication and Signaling
35 papers in training set
Top 1%
0.7%
28
Cancer Cell
38 papers in training set
Top 2%
0.7%
29
Molecular Biology of the Cell
272 papers in training set
Top 3%
0.7%
30
Molecular Cancer Therapeutics
33 papers in training set
Top 0.7%
0.7%